Howard Berman - 09 Jan 2025 Form 4 Insider Report for Coya Therapeutics, Inc. (COYA)

Role
Director
Signature
/s/ David Snyder, Attorney-in-Fact
Issuer symbol
COYA
Transactions as of
09 Jan 2025
Net transactions value
$0
Form type
4
Filing time
13 Jan 2025, 08:00:03 UTC
Previous filing
05 Jun 2024
Next filing
24 Jun 2025
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction COYA Stock Option (right to buy) Award $0 +150,602 $0.000000 150,602 09 Jan 2025 Common Stock, par value $0.0001 per share 150,602 $6.07 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The option will vest in monthly installments over 36 months commencing on February 9, 2025, subject to continuous service on each vesting date.